Regular Article
Potential Cholestatic Activity of Various Therapeutic Agents Assessed by Bile Canalicular Membrane Vesicles Isolated from Rats and Humans

https://doi.org/10.2133/dmpk.18.16Get rights and content

Summary:

The active transport of solutes mediated by the bile salt export pump (BSEP/ABCB11) and multidrug resistance associated protein-2 (MRP2/ABCC2) are thought to involve bile acid-dependent and -independent bile formation, respectively. To evaluate the potential of therapeutic agents as inhibitors of such transporters on bile canalicular membranes, we examined the inhibition of the primary active transport of typical substrates by 15 drugs, clinically known to cause cholestasis in canalicular membrane vesicles. The inhibition by most of the compounds in rat canalicular membrane vesicles (CMVs) was minimal or observed at much higher concentrations than obtained in clinical situations. However, cloxacillin, cyclosporin A and midecamycin inhibited BSEP, and cyclosporin A and midecamycin inhibited MRP2 with an inhibition constant close to the clinical concentration. By comparing the inhibition potential between rat and human CMVs, the inhibition of BSEP- and MRP2-mediated transport by midecamycin and cyclosporin A was relatively similar whereas the inhibitory effect on BSEP-mediated transport by cloxacillin and glibenclamide was more marked in humans than in rats. These results suggest that the majority of cholestasis-inducing drugs have a minimal inhibitory effect on rat BSEP and MRP2 although species differences in inhibitory potential should be considered, especially in the case of BSEP.

References (37)

  • K. Niinuma et al.

    Primary active transport of organic anions on bile canalicular membrane in humans

    Am. J. Physiol.

    (1999)
  • Y. Yamaoka et al.

    A pharmacokinetic analysis program (MULTI) for microcomputer

    J. Pharmacobio.-Dyn.

    (1981)
  • K. Ito et al.

    Quantitative prediction of in vivo drug clearance and drug interactions from in vitro data on metabolism, together with binding and transport

    Annu Rev Pharmacol Toxicol.

    (1998)
  • K. Komatsu et al.

    Prediction of in vivo drug-drug interactions between tolbutamide and various sulfonamides in humans based on in vitro experiments

    Drug Metab Dispos.

    (2000)
  • K. Ito et al.

    Prediction of pharmacokinetic alterations caused by drug-drug interactions: Metabolic interaction in the liver

    Pharmacol. Rev.

    (1998)
  • J.F. Cadranel et al.

    Chronic administration of cyclosporin A induces a decrease in hepatic excretory function in man

    Dig. Dis. Sci.

    (1992)
  • B.J. Bruns

    Colchicine toxicity

    Australasian annals of Medicine.

    (1969)
  • C. Funk et al.

    Cholestatic potential of troglitazone as a possible factor contributing to troglitazone-induced hepatotoxicity: In vivo and in vitro interaction at the canalicular bile salt export pump (Bsep) in the rat

    Mol. Pharmacol.

    (2000)
  • Cited by (0)

    View full text